---

Blood Report Analysis — Amit Kishor | Male, 38 Years | Collected 27/Apr/2026

---

Complete Summary of Results

---

Diagnoses

1. 🔴 PRIMARY DIAGNOSIS: Subclinical Hypothyroidism (likely causing secondary dyslipidaemia)

• Severe hypertriglyceridaemia (impaired lipoprotein lipase activity)
• Low HDL
• Elevated VLDL
• Elevated liver enzymes (ALT, GGT)
• Microcytic/hypochromic picture (hypothyroidism impairs iron absorption and erythropoiesis)
• Hypocalcaemia (reduced intestinal calcium absorption)
• Glucose dysregulation

2. 🔴 Severe Hypertriglyceridaemia / Mixed Dyslipidaemia

• TG = 561.4 mg/dL (very high; risk of pancreatitis begins at >500 mg/dL)
• HDL = 29.2 mg/dL (critically low)
• VLDL = 49 mg/dL (elevated)
• Sample was noted as grossly lipaemic — confirms severe hypertriglyceridaemia
• Meets criteria for Metabolic Syndrome (high TG + low HDL + elevated fasting glucose)

3. 🟡 Prediabetes (ADA Criteria — BOTH criteria fulfilled)

Important note: HbA1c of 6.5% technically meets the ADA threshold for Type 2 Diabetes Mellitus (≥6.5%), but the lab's own reference range (and the ADA 2023 guideline printed in the report) lists 5.7–6.4% as prediabetes and ≥6.5% as "Diagnosing Diabetes." This requires confirmation with a repeat test on a separate day or an OGTT to formally establish the diagnosis of T2DM.

4. 🟡 Microcytic Hypochromic Anaemia — likely Iron Deficiency or Thalassaemia Trait

• Hb = 12.8 g/dL (low for male), MCV = 65.4 fL (severely microcytic), MCH = 20.7 pg (hypochromic)
• RDW-CV = 17.5% (elevated — suggests anisocytosis, more consistent with iron deficiency)
• Mentzer Index = 10.58 (MCV ÷ RBC = 65.4 ÷ 6.18 = 10.58; >13 → Iron Deficiency Anaemia, <13 → Thalassaemia)
• However, ferritin (148.4 ng/mL) and serum iron (142.7 µg/dL) are normal — this makes simple IDA unlikely
• The combination of low MCV, elevated RDW, normal ferritin/iron, and elevated RBC count (6.18 × 10⁶/µL — upper normal) raises strong suspicion for Beta-Thalassaemia Trait or a mixed picture compounded by hypothyroidism

5. 🟡 Vitamin D Deficiency (Severe) + Low Calcium

• Vitamin D = 7.23 ng/mL (severe deficiency: <20 ng/mL)
• Calcium = 8.6 mg/dL (below normal lower limit of 8.8 mg/dL)
• This combination is consistent — vitamin D is required for intestinal calcium absorption

6. 🟡 Vitamin B12 Deficiency

• B12 = 157 pg/mL (low; reference 211–912 pg/mL)
• Can contribute to fatigue, neuropathic symptoms, and macrocytosis (masking the microcytic picture here)

7. 🟠 Hepatic Steatosis / Non-Alcoholic Fatty Liver Disease (NAFLD) — Suspected

• ALT = 57.6 U/L (elevated), GGT = 87.9 U/L (elevated)
• In the context of severe hypertriglyceridaemia, prediabetes/diabetes, and hypothyroidism, NAFLD/hepatic steatosis is the most likely cause

---

Further Tests to Confirm Each Diagnosis

To Confirm Subclinical Hypothyroidism / Rule Out Autoimmune Cause

To Confirm/Stage Diabetes vs. Prediabetes

To Characterise the Anaemia

To Assess Liver (NAFLD/NASH vs. Other)

To Assess Cardiovascular Risk (Given Severe TG + Low HDL)

To Assess Vitamin D / Calcium Axis

---

Clinical Summary

• Severe secondary hypertriglyceridaemia (TG 561 mg/dL) with low HDL
• Transaminitis (ALT/GGT elevation) via hepatic fat accumulation
• Contribution to glucose dysregulation (HbA1c at diabetic threshold)
• Anaemia via reduced erythropoietin sensitivity and iron utilisation

1. Anti-TPO antibody — to confirm Hashimoto's thyroiditis
2. Free T4 — to determine whether thyroid hormone replacement is needed immediately
3. Haemoglobin electrophoresis (HPLC) — to exclude beta-thalassaemia trait
4. OGTT — to formally classify diabetes vs. prediabetes
5. Abdominal ultrasound — to assess hepatic steatosis and rule out pancreatitis (given TG >500 mg/dL)

⚠️ Triglycerides of 561 mg/dL place this patient at immediate risk of acute pancreatitis. Urgent lipid-lowering therapy (fibrate + omega-3) and dietary fat restriction should not wait for confirmatory testing.